PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The TM6SF2 gene variant is associated with increased risks of NAFLD, NASH, and advanced fibrosis independent of age, body mass index (BMI), presence of diabetes, and PNPLA3 genotype status (Liu et al., 2014; Sookoian et al., 2015).